SCHEMBL4196509

SCHEMBL4196509

Cc1cc(-c2sc(N3CCN(Cc4ccc(F)cc4)C3)nc2C)n[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 7/20 0.39
KDM4E B2RXH2 1/20 0.38
AURKA O14965 1/20 0.38
NTRK1 P04629 1/20 0.38
POLB P06746 1/20 0.37
HTR1A P08908 2/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
ACHE P22303 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 2/20 0.36
SCD O00767 1/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL243192 0.80 SCD (0.59) COMTKDM4EPOLBMAPTRAB9A
SCHEMBL4349824 0.73 COMT (0.37) COMTAURKAMAPTSCD
SCHEMBL240551 0.70 SCD (0.47) KDM4EPOLBMAPTRAB9ASCD
SCHEMBL1911665 0.65 SCD (0.47) COMTKDM4EPOLBSCDMEN1
SCHEMBL348021 0.64 SCD (0.45) KDM4EPOLBDRD2DRD3SCD
SCHEMBL5016248 0.63 RAB9A (0.56) KDM4EDRD2RAB9AMEN1NPC1
SCHEMBL5016245 0.63 RAB9A (0.56) KDM4EDRD2RAB9AMEN1NPC1
SCHEMBL2577772 0.63 SCD (0.33) KDM4ESCD
SCHEMBL22642436 0.63 MAPT (0.61) KDM4EMAPT
SCHEMBL348517 0.62 SCD (0.47) COMTDRD2SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed